WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :

Download Article: Click Here

Search

Track Your Article

Abstract

THE SARS-COV-2-DELTA VARIANT IS A BITTER TRUTH THAT MUST BE FACED EVEN IN THE PRESENCE OF VACCINES

Mohammed G. Maslub* and Zeyad A. Abdalla

Abstract

In October 2020, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta mutant variant was identified in India, and then it spread to various countries all over the world. This form of the virus was linked to significant Coronavirus disease 2019 (Covid-19) vaccines breakthrough severe infection, hospitalization and mortalities. Novel variants of the virus that are resistant to vaccines could infect millions of fully vaccinated people all over the world after countries opening up. Consequently, both practicing safety measures to reduce SARS-CoV-2 spreading, and increasing the vaccination rate should be implemented to avoid the expected catastrophic complications of this brutal Delta variant of the virus.

Keywords: SARS-CoV-2, Covid-19, Delta variant, Transmission, Vaccination.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More